O	0	11	Prospective
O	12	22	comparison
O	23	25	of
B-intervention	26	37	peritumoral
I-intervention	38	41	and
I-intervention	42	52	subareolar
I-intervention	53	62	injection
I-intervention	63	65	of
I-intervention	66	70	blue
I-intervention	71	74	dye
I-intervention	75	80	alone
O	80	81	,
O	82	85	for
O	86	100	identification
O	101	103	of
O	104	112	sentinel
O	113	118	lymph
O	119	124	nodes
O	125	127	in
O	128	136	patients
O	137	141	with
O	142	147	early
O	148	153	stage
O	154	160	breast
O	161	167	cancer
O	167	168	.

O	169	176	Various
O	177	187	techniques
O	188	191	are
O	192	196	used
O	197	200	for
O	201	204	the
O	205	219	identification
O	220	222	of
O	223	226	the
O	227	235	sentinel
O	236	240	node
O	241	242	(
O	242	245	SLN
O	245	246	)
O	246	247	.

O	248	250	We
O	251	264	prospectively
O	265	272	compare
O	273	276	the
O	277	285	efficacy
O	286	288	of
O	289	292	SLN
O	293	299	biopsy
O	300	303	and
O	304	307	the
O	308	314	number
O	315	317	of
O	318	322	SLNs
O	323	333	identified
O	333	334	,
O	335	337	by
O	338	347	injecting
O	348	357	methylene
O	358	362	blue
O	363	364	(
O	364	366	MB
O	366	367	)
O	368	373	alone
O	374	376	in
O	377	380	the
O	381	391	subareolar
O	392	396	area
O	397	398	(
O	398	400	SA
O	400	401	)
O	402	404	or
O	405	418	peritumorally
O	419	420	(
O	420	422	PT
O	422	423	)
O	424	426	in
B-eligibility	427	435	patients
I-eligibility	436	440	with
I-eligibility	441	446	early
I-eligibility	447	452	stage
I-eligibility	453	459	breast
I-eligibility	460	466	cancer
O	466	467	.

O	468	476	Patients
O	477	481	were
O	482	492	randomized
O	493	495	in
O	496	499	two
O	500	506	groups
O	507	508	(
O	508	510	SA
O	511	513	or
B-control	514	516	PT
I-control	517	526	injection
O	526	527	)
O	527	528	.

O	529	530	A
O	531	537	linear
O	538	548	regression
O	549	554	model
O	555	558	was
O	559	563	used
O	564	566	to
O	567	575	estimate
O	576	579	the
O	580	586	effect
O	587	589	of
O	590	597	various
O	598	608	parameters
O	609	611	on
O	612	615	the
O	616	630	identification
O	631	635	rate
O	636	639	and
O	640	642	on
O	643	646	the
O	647	653	number
O	654	656	of
O	657	661	SLNs
O	662	671	retrieved
O	671	672	.

O	673	675	At
O	676	681	least
O	682	685	one
B-outcome	686	689	SLN
O	690	693	was
O	694	704	identified
O	705	707	in
B-iv-bin-abs	708	710	61
O	711	713	of
B-intervention-participants	714	716	66
O	717	718	(
B-iv-bin-percent	718	720	92
I-iv-bin-percent	720	721	.
I-iv-bin-percent	721	722	4
I-iv-bin-percent	722	723	%
O	723	724	)
O	725	735	procedures
O	736	738	in
O	739	742	the
O	743	745	SA
O	746	751	group
O	752	755	and
O	756	758	in
B-cv-bin-abs	759	761	57
O	762	764	of
B-control-participants	765	767	60
O	768	769	(
B-cv-bin-percent	769	771	95
I-cv-bin-percent	771	772	%
O	772	773	)
O	774	784	procedures
O	785	787	in
O	788	791	the
O	792	794	PT
O	795	800	group
O	801	802	(
O	802	803	P
O	804	805	=
O	806	807	0
O	807	808	.
O	808	810	55
O	810	811	)
O	811	812	.

O	813	816	The
B-outcome	817	821	mean
I-outcome	822	828	number
I-outcome	829	831	of
I-outcome	832	836	SLNs
I-outcome	837	844	removed
O	845	849	with
O	850	853	the
O	854	856	SA
O	857	866	injection
O	867	873	method
O	874	877	was
B-iv-cont-mean	878	879	1
I-iv-cont-mean	879	880	.
I-iv-cont-mean	880	882	64
O	883	884	±
B-iv-cont-sd	885	886	0
I-iv-cont-sd	886	887	.
I-iv-cont-sd	887	888	6
O	889	894	nodes
O	895	903	compared
O	904	908	with
B-cv-cont-mean	909	910	2
I-cv-cont-mean	910	911	.
I-cv-cont-mean	911	913	23
O	914	915	±
B-cv-cont-sd	916	917	0
I-cv-cont-sd	917	918	.
I-cv-cont-sd	918	919	7
O	920	925	nodes
O	926	936	identified
O	937	941	with
O	942	945	the
O	946	948	PT
O	949	958	injection
O	959	960	(
O	960	965	range
O	965	966	:
O	967	968	1
O	968	969	-
O	969	970	4
O	970	971	,
O	972	973	P
O	974	975	<
O	976	977	0
O	977	978	.
O	978	981	001
O	981	982	)
O	982	983	.

O	984	987	The
O	988	997	injection
O	998	1002	site
O	1003	1006	was
O	1007	1010	the
O	1011	1015	only
O	1016	1022	factor
O	1023	1032	affecting
O	1033	1036	the
O	1037	1043	number
O	1044	1046	of
O	1047	1051	SLNs
O	1052	1061	retrieved
O	1061	1062	.

O	1063	1066	The
O	1067	1070	use
O	1071	1073	of
O	1074	1076	MB
O	1077	1082	alone
O	1083	1085	is
O	1086	1088	an
O	1089	1098	efficient
O	1099	1105	method
O	1106	1109	for
O	1110	1124	identification
O	1125	1127	of
O	1128	1131	the
O	1132	1135	SLN
O	1135	1136	.

O	1137	1140	The
O	1141	1143	PT
O	1144	1153	injection
O	1154	1159	route
O	1160	1166	yields
O	1167	1168	a
O	1169	1175	higher
O	1176	1182	number
O	1183	1185	of
O	1186	1190	SLNs
O	1191	1195	than
O	1196	1199	the
O	1200	1202	SA
O	1203	1208	route
O	1208	1209	,
O	1210	1220	comparable
O	1221	1225	with
O	1226	1229	the
O	1230	1236	number
O	1237	1239	of
O	1240	1244	SLNs
O	1245	1254	retrieved
O	1254	1255	,
O	1256	1260	when
O	1261	1269	combined
O	1270	1277	tracing
O	1278	1284	agents
O	1285	1288	and
O	1289	1297	multiple
O	1298	1307	injection
O	1308	1313	sites
O	1314	1317	are
O	1318	1322	used
O	1322	1323	.
